Additional tests may include methylmalonic acid, intrinsic factor antibodies, and investigation for malabsorption conditions following British Society for Haematology and NICE guidance
When looking at people who fully adhered to the medication schedule (a weekly injection under the skin), those on the 7.2 milligram dose lost an average 20.7% body weight after 72 weeks, compared to 17.5% lost body weight for the 2.4 milligram group, and 2.4% lost body weight for the placebo group
Ashcroft GS, et al
At RescueMD, we focus on a medical, personalized, and evidence-based approach
These estimates were based on patients with available follow-up weight measurements, representing a subset of the full study population
This will ensure the rollout of tirzepatide reaches everyone who is eligible in a safe and effective way. The latest Health Survey for England shows 64% of adults were overweight or obese in 2022